[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-001", "question": "A 58-year-old man with a history of hypertrophic cardiomyopathy presents with recurrent syncope. Genetic testing reveals a mutation in the MYH7 gene. Echocardiography shows asymmetric septal hypertrophy with a left ventricular outflow tract gradient of 80 mmHg at rest. Despite optimal medical therapy with beta-blockers, he continues to experience symptoms. What is the most appropriate next step in management?", "options": ["Implantable cardioverter-defibrillator placement", "Septal myectomy", "Alcohol septal ablation", "Dual-chamber pacing", "Mavacamten initiation"], "answer": "E", "answer_index": 4, "explanation": "Mavacamten is the most appropriate next step as it is a cardiac myosin inhibitor specifically indicated for symptomatic obstructive hypertrophic cardiomyopathy refractory to beta-blockers, targeting the underlying pathophysiology. Septal myectomy and alcohol septal ablation are invasive options reserved for cases not responding to medical therapy, but mavacamten offers a non-invasive alternative with recent evidence supporting its use before procedural interventions. Implantable cardioverter-defibrillator and dual-chamber pacing address arrhythmic risks but not the outflow obstruction directly.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 58-year-old man with obstructive HCM (LVOT gradient 80 mmHg at rest), recurrent syncope despite optimal beta-blocker therapy. Key discriminating findings: symptomatic obstruction refractory to medical therapy, significant resting gradient (≥50 mmHg), recurrent syncope. The question asks for \\\"most appropriate next step.\\\" Option E (mavacamten) is a newer medical therapy FDA-approved for obstructive HCM, offering non-invasive gradient reduction. However, Option B (septal myectomy) represents the gold-standard invasive therapy for drug-refractory obstructive HCM with established long-term outcomes and guideline support (Class I recommendation in appropriate centers). The rationale states mavacamten should be tried \\\"before procedural interventions,\\\" but this sequencing is not universally established in guidelines; many centers proceed directly to septal reduction therapy after conventional medical therapy fails. The stem's phrase \\\"optimal medical therapy with beta-blockers\\\" is ambiguous—does this exclude other medications (disopyramide, verapamil) or only beta-blockers? If only beta-blockers were tried, adding mavacamten is reasonable; if all medical options failed, septal myectomy becomes more defensible. Both B and E are defensible depending on interpretation of \\\"optimal medical therapy\\\" and institutional practice patterns. Minimal fix: Specify whether disopyramide/verapamil were tried and failed, or explicitly state preference for exhausting all medical options before invasive therapy.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a 58-year-old man with obstructive HCM (LVOT gradient 80 mmHg at rest), recurrent syncope despite optimal beta-blocker therapy. Key discriminating findings: symptomatic obstruction refractory to medical therapy, significant resting gradient (≥50 mmHg), recurrent syncope. The question asks for \"most appropriate next step.\" Option E (mavacamten) is a newer medical therapy FDA-approved for obstructive HCM, offering non-invasive gradient reduction. However, Option B (septal myectomy) represents the gold-standard invasive therapy for drug-refractory obstructive HCM with established long-term outcomes and guideline support (Class I recommendation in appropriate centers). The rationale states mavacamten should be tried \"before procedural interventions,\" but this sequencing is not universally established in guidelines; many centers proceed directly to septal reduction therapy after conventional medical therapy fails. The stem's phrase \"optimal medical therapy with beta-blockers\" is ambiguous—does this exclude other medications (disopyramide, verapamil) or only beta-blockers? If only beta-blockers were tried, adding mavacamten is reasonable; if all medical options failed, septal myectomy becomes more defensible. Both B and E are defensible depending on interpretation of \"optimal medical therapy\" and institutional practice patterns. Minimal fix: Specify whether disopyramide/verapamil were tried and failed, or explicitly state preference for exhausting all medical options before invasive therapy.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-002", "question": "A 72-year-old woman with Parkinson's disease develops sudden onset of severe headache, vomiting, and left-sided hemiparesis. MRI reveals a right thalamic hemorrhage with intraventricular extension. She is on carbidopa-levodopa and has a history of orthostatic hypotension. What is the most likely underlying mechanism contributing to this event?", "options": ["Cerebral amyloid angiopathy", "Hypertensive vasculopathy", "Levodopa-induced vasospasm", "Orthostatic hypotension-related watershed infarction", "Dopaminergic therapy-associated coagulopathy"], "answer": "B", "answer_index": 1, "explanation": "Hypertensive vasculopathy is the most likely mechanism, as chronic hypertension in elderly patients with Parkinson's often leads to small vessel disease and thalamic hemorrhages. Cerebral amyloid angiopathy typically affects cortical regions, not deep structures like the thalamus. Levodopa does not directly cause vasospasm or coagulopathy, and while orthostatic hypotension is common, it more often results in ischemic rather than hemorrhagic events.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: U (Underspecified, leading to M). Verdict: Not uniquely determinable. The vignette describes a 72-year-old woman with Parkinson's disease presenting with thalamic hemorrhage but critically omits any mention of hypertension history or blood pressure measurements. The stem states she has orthostatic hypotension but provides no data on baseline or current blood pressure status. Key discriminating findings: elderly patient, thalamic hemorrhage with intraventricular extension, Parkinson's disease, orthostatic hypotension history. The keyed answer (B: Hypertensive vasculopathy) requires assuming chronic hypertension exists, which is never stated. The rationale claims \\\"chronic hypertension in elderly patients with Parkinson's\\\" but this is not established in the vignette. Option A (Cerebral amyloid angiopathy) is also defensible in a 72-year-old with deep hemorrhage, as CAA can affect deep structures in elderly patients, though lobar location is more typical. Without explicit hypertension documentation, both answers remain plausible. Main logical issue: critical missing detail (hypertension status) prevents unique best-answer determination. Main medical accuracy issue: the rationale assumes facts not in evidence. Minimal fix: Add \\\"with poorly controlled hypertension (BP 180/95 mmHg)\\\" to the stem to unambiguously support hypertensive vasculopathy as the mechanism.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified, leading to M). Verdict: Not uniquely determinable. The vignette describes a 72-year-old woman with Parkinson's disease presenting with thalamic hemorrhage but critically omits any mention of hypertension history or blood pressure measurements. The stem states she has orthostatic hypotension but provides no data on baseline or current blood pressure status. Key discriminating findings: elderly patient, thalamic hemorrhage with intraventricular extension, Parkinson's disease, orthostatic hypotension history. The keyed answer (B: Hypertensive vasculopathy) requires assuming chronic hypertension exists, which is never stated. The rationale claims \"chronic hypertension in elderly patients with Parkinson's\" but this is not established in the vignette. Option A (Cerebral amyloid angiopathy) is also defensible in a 72-year-old with deep hemorrhage, as CAA can affect deep structures in elderly patients, though lobar location is more typical. Without explicit hypertension documentation, both answers remain plausible. Main logical issue: critical missing detail (hypertension status) prevents unique best-answer determination. Main medical accuracy issue: the rationale assumes facts not in evidence. Minimal fix: Add \"with poorly controlled hypertension (BP 180/95 mmHg)\" to the stem to unambiguously support hypertensive vasculopathy as the mechanism.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-003", "question": "A 45-year-old man with type 1 diabetes mellitus presents with recurrent hypoglycemia despite dose adjustments. He has a history of autoimmune thyroiditis and vitiligo. Laboratory evaluation shows low morning cortisol and elevated ACTH. What is the most appropriate confirmatory test for the suspected diagnosis?", "options": ["Cosyntropin stimulation test", "Insulin tolerance test", "21-Hydroxylase antibody assay", "Adrenal CT scan", "Metyrapone test"], "answer": "C", "answer_index": 2, "explanation": "21-Hydroxylase antibody assay is the most appropriate confirmatory test for autoimmune adrenalitis in the context of polyglandular autoimmune syndrome type 2, given the patient's other autoimmune conditions. Cosyntropin stimulation test assesses adrenal reserve but does not confirm etiology. Insulin tolerance and metyrapone tests evaluate the hypothalamic-pituitary-adrenal axis but are less specific for autoimmune causes, and adrenal CT is imaging that may show atrophy but not confirm autoimmunity.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed – a unique best answer exists (A), but the key is C. The stem describes a 45-year-old man with type 1 diabetes, autoimmune thyroiditis, vitiligo, recurrent hypoglycemia, low morning cortisol, and elevated ACTH – classic for primary adrenal insufficiency (Addison's disease) in polyglandular autoimmune syndrome type 2 (PAS-2). The question asks for the \\\"most appropriate confirmatory test for the suspected diagnosis.\\\" The suspected diagnosis is primary adrenal insufficiency, not its autoimmune etiology. Cosyntropin stimulation test (A) is the gold-standard confirmatory test for adrenal insufficiency, demonstrating inadequate cortisol response. 21-Hydroxylase antibody assay (C) confirms autoimmune etiology but does not confirm adrenal insufficiency itself; antibodies can be present without functional impairment, and their absence doesn't exclude autoimmune adrenalitis. Standard practice requires functional confirmation (cosyntropin test) before etiologic workup. The rationale conflates \\\"confirming the diagnosis\\\" (adrenal insufficiency) with \\\"confirming the etiology\\\" (autoimmune). Medical accuracy issue: The keyed answer misidentifies the primary diagnostic step. Minimal fix: Change key to A, or reword question to \\\"What test would best confirm the autoimmune etiology?\\\" to make C correct.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed – a unique best answer exists (A), but the key is C. The stem describes a 45-year-old man with type 1 diabetes, autoimmune thyroiditis, vitiligo, recurrent hypoglycemia, low morning cortisol, and elevated ACTH – classic for primary adrenal insufficiency (Addison's disease) in polyglandular autoimmune syndrome type 2 (PAS-2). The question asks for the \"most appropriate confirmatory test for the suspected diagnosis.\" The suspected diagnosis is primary adrenal insufficiency, not its autoimmune etiology. Cosyntropin stimulation test (A) is the gold-standard confirmatory test for adrenal insufficiency, demonstrating inadequate cortisol response. 21-Hydroxylase antibody assay (C) confirms autoimmune etiology but does not confirm adrenal insufficiency itself; antibodies can be present without functional impairment, and their absence doesn't exclude autoimmune adrenalitis. Standard practice requires functional confirmation (cosyntropin test) before etiologic workup. The rationale conflates \"confirming the diagnosis\" (adrenal insufficiency) with \"confirming the etiology\" (autoimmune). Medical accuracy issue: The keyed answer misidentifies the primary diagnostic step. Minimal fix: Change key to A, or reword question to \"What test would best confirm the autoimmune etiology?\" to make C correct.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-004", "question": "A 60-year-old smoker with COPD presents with progressive dyspnea and hemoptysis. CT chest reveals a 2 cm spiculated nodule in the right upper lobe with mediastinal lymphadenopathy. Bronchoscopy with biopsy confirms squamous cell carcinoma. PET-CT shows no distant metastases. What is the most appropriate initial management?", "options": ["Stereotactic body radiotherapy", "Surgical lobectomy with lymph node dissection", "Concurrent chemoradiotherapy", "Immune checkpoint inhibitor monotherapy", "Epidermal growth factor receptor tyrosine kinase inhibitor"], "answer": "B", "answer_index": 1, "explanation": "Surgical lobectomy with lymph node dissection is the most appropriate for stage I squamous cell lung cancer in a patient with adequate pulmonary reserve, offering the best chance for cure. Stereotactic body radiotherapy is an alternative for non-surgical candidates, but this patient has no contraindications mentioned. Chemoradiotherapy and targeted therapies are for more advanced stages or specific molecular profiles not indicated here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a 60-year-old smoker with COPD, 2 cm spiculated nodule, and mediastinal lymphadenopathy on CT. The presence of mediastinal lymphadenopathy is critical—it suggests N2 disease (stage IIIA), not stage I as claimed in the rationale. The stem does not specify: (1) whether lymphadenopathy is confirmed pathologically (required for staging), (2) pulmonary function test results or surgical candidacy in a COPD patient, or (3) exact nodal station involvement. Key stem clues: mediastinal lymphadenopathy contradicts stage I classification; COPD raises concern about surgical reserve. If nodes are truly N2, concurrent chemoradiotherapy (C) is standard, making it defensible. If nodes are false-positive and disease is actually stage I with adequate pulmonary function, surgical lobectomy (B) is correct. The keyed answer assumes stage I and surgical candidacy without providing the necessary staging confirmation or functional assessment. Main logical issue: critical staging ambiguity prevents unique best-answer determination. Main medical accuracy issue: rationale incorrectly states stage I despite mediastinal lymphadenopathy. Minimal fix: specify 'mediastinal lymph nodes are PET-negative/biopsy-negative' and include 'FEV1 >60% predicted' to establish stage IA and surgical candidacy.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a 60-year-old smoker with COPD, 2 cm spiculated nodule, and mediastinal lymphadenopathy on CT. The presence of mediastinal lymphadenopathy is critical—it suggests N2 disease (stage IIIA), not stage I as claimed in the rationale. The stem does not specify: (1) whether lymphadenopathy is confirmed pathologically (required for staging), (2) pulmonary function test results or surgical candidacy in a COPD patient, or (3) exact nodal station involvement. Key stem clues: mediastinal lymphadenopathy contradicts stage I classification; COPD raises concern about surgical reserve. If nodes are truly N2, concurrent chemoradiotherapy (C) is standard, making it defensible. If nodes are false-positive and disease is actually stage I with adequate pulmonary function, surgical lobectomy (B) is correct. The keyed answer assumes stage I and surgical candidacy without providing the necessary staging confirmation or functional assessment. Main logical issue: critical staging ambiguity prevents unique best-answer determination. Main medical accuracy issue: rationale incorrectly states stage I despite mediastinal lymphadenopathy. Minimal fix: specify 'mediastinal lymph nodes are PET-negative/biopsy-negative' and include 'FEV1 >60% predicted' to establish stage IA and surgical candidacy.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-005", "question": "A 35-year-old woman in the emergency department presents with chest pain, palpitations, and diaphoresis after using cocaine. ECG shows ST-segment elevation in leads V2-V4. Troponin is elevated. Coronary angiography reveals a thrombus in the left anterior descending artery with no underlying atherosclerosis. What is the most appropriate immediate management?", "options": ["Intracoronary thrombolysis", "Percutaneous coronary intervention with stenting", "Systemic anticoagulation with heparin", "Glycoprotein IIb/IIIa inhibitor infusion", "Aspiration thrombectomy"], "answer": "E", "answer_index": 4, "explanation": "Aspiration thrombectomy is the most appropriate for cocaine-induced myocardial infarction due to vasospasm and thrombus without atherosclerosis, allowing removal of the clot while minimizing vessel trauma. Stenting is unnecessary without plaque, and thrombolysis carries bleeding risks. Anticoagulation and glycoprotein inhibitors are adjunctive but not primary interventions for isolated thrombus.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer (E) is not the best answer; B is the correct best answer. Key stem clues: 35-year-old woman with cocaine use, STEMI (ST-elevation V2-V4), elevated troponin, angiography showing LAD thrombus without atherosclerosis. This is cocaine-induced STEMI requiring immediate reperfusion. Main logical issue: The item has a defensible unique best answer (PCI), but the key incorrectly identifies aspiration thrombectomy. In contemporary practice and guidelines, PCI (option B) is the standard immediate management for STEMI regardless of etiology. While aspiration thrombectomy can be performed during PCI, it is not the primary intervention and current evidence (TOTAL trial, TASTE trial) shows routine aspiration thrombectomy does not improve outcomes and is no longer recommended as standard practice. The rationale incorrectly suggests stenting is unnecessary without plaque, but PCI encompasses both thrombectomy and stenting as needed, and is the definitive reperfusion strategy. Medical accuracy issue: The explanation misrepresents current STEMI management guidelines which prioritize PCI as the immediate intervention. Minimal fix: Change the correct answer key from E to B, or rewrite option B to exclude PCI and make aspiration thrombectomy the only mechanical intervention offered.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer (E) is not the best answer; B is the correct best answer. Key stem clues: 35-year-old woman with cocaine use, STEMI (ST-elevation V2-V4), elevated troponin, angiography showing LAD thrombus without atherosclerosis. This is cocaine-induced STEMI requiring immediate reperfusion. Main logical issue: The item has a defensible unique best answer (PCI), but the key incorrectly identifies aspiration thrombectomy. In contemporary practice and guidelines, PCI (option B) is the standard immediate management for STEMI regardless of etiology. While aspiration thrombectomy can be performed during PCI, it is not the primary intervention and current evidence (TOTAL trial, TASTE trial) shows routine aspiration thrombectomy does not improve outcomes and is no longer recommended as standard practice. The rationale incorrectly suggests stenting is unnecessary without plaque, but PCI encompasses both thrombectomy and stenting as needed, and is the definitive reperfusion strategy. Medical accuracy issue: The explanation misrepresents current STEMI management guidelines which prioritize PCI as the immediate intervention. Minimal fix: Change the correct answer key from E to B, or rewrite option B to exclude PCI and make aspiration thrombectomy the only mechanical intervention offered.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-006", "question": "A 68-year-old man with atrial fibrillation on anticoagulation develops acute right-sided weakness. CT head shows no hemorrhage, and MRI confirms acute ischemic stroke in the left middle cerebral artery territory. He is within 4.5 hours of symptom onset. What is the most critical factor determining eligibility for intravenous thrombolysis?", "options": ["International normalized ratio value", "Time since last anticoagulant dose", "Presence of atrial fibrillation", "Stroke severity on NIHSS scale", "Reversal agent availability"], "answer": "A", "answer_index": 0, "explanation": "The international normalized ratio value is the most critical, as thrombolysis is contraindicated if INR >1.7 in patients on vitamin K antagonists to avoid hemorrhagic complications. Time since last dose affects coagulopathy but INR directly measures it. Atrial fibrillation and stroke severity influence overall management but not thrombolysis eligibility directly, and reversal agents are for bleeding, not pre-thrombolysis.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem states the patient is \\\"on anticoagulation\\\" but fails to specify which anticoagulant. This critical omission creates ambiguity: if the patient is on warfarin (vitamin K antagonist), INR >1.7 is indeed a contraindication per AHA/ASA guidelines, making option A correct. However, if the patient is on a direct oral anticoagulant (DOAC) like apixaban or rivaroxaban—increasingly common for atrial fibrillation—INR is not relevant for assessing coagulopathy; instead, time since last dose (option B) becomes the critical factor, as DOACs have predictable half-lives and thrombolysis eligibility depends on adequate washout time (typically >48 hours for dabigatran, >24 hours for others). The stem's failure to specify the anticoagulant type makes both A and B defensible depending on unstated assumptions. Medical accuracy: The keyed answer and rationale are correct for warfarin but ignore DOAC scenarios, which represent a significant proportion of anticoagulated AF patients. Minimal fix: Specify \\\"on warfarin\\\" in the stem to make INR unambiguously the correct answer.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem states the patient is \"on anticoagulation\" but fails to specify which anticoagulant. This critical omission creates ambiguity: if the patient is on warfarin (vitamin K antagonist), INR >1.7 is indeed a contraindication per AHA/ASA guidelines, making option A correct. However, if the patient is on a direct oral anticoagulant (DOAC) like apixaban or rivaroxaban—increasingly common for atrial fibrillation—INR is not relevant for assessing coagulopathy; instead, time since last dose (option B) becomes the critical factor, as DOACs have predictable half-lives and thrombolysis eligibility depends on adequate washout time (typically >48 hours for dabigatran, >24 hours for others). The stem's failure to specify the anticoagulant type makes both A and B defensible depending on unstated assumptions. Medical accuracy: The keyed answer and rationale are correct for warfarin but ignore DOAC scenarios, which represent a significant proportion of anticoagulated AF patients. Minimal fix: Specify \"on warfarin\" in the stem to make INR unambiguously the correct answer.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-007", "question": "A 52-year-old woman with acromegaly undergoes transsphenoidal surgery. Postoperatively, she develops polyuria with urine output exceeding 300 mL/hour. Serum sodium is 148 mEq/L, and urine specific gravity is 1.002. What is the most appropriate initial pharmacologic intervention?", "options": ["Desmopressin acetate", "Hydrochlorothiazide", "Demeclocycline", "Tolvaptan", "Conivaptan"], "answer": "A", "answer_index": 0, "explanation": "Desmopressin acetate is the most appropriate for central diabetes insipidus following pituitary surgery, replacing deficient antidiuretic hormone to concentrate urine. Hydrochlorothiazide is used for nephrogenic diabetes insipidus, not central. Demeclocycline and vasopressin antagonists like tolvaptan or conivaptan are for syndrome of inappropriate antidiuretic hormone, which would worsen hypernatremia here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes classic postoperative central diabetes insipidus (DI) after transsphenoidal pituitary surgery: polyuria (>300 mL/hr), hypernatremia (148 mEq/L), and dilute urine (specific gravity 1.002). Key discriminating findings are the surgical context (pituitary stalk injury), massive urine output, elevated serum sodium, and inappropriately dilute urine indicating ADH deficiency. The keyed answer (desmopressin) is the standard first-line treatment for central DI, directly replacing deficient ADH. Option B (hydrochlorothiazide) treats nephrogenic DI via paradoxical antidiuresis but is inappropriate for central DI. Options C, D, and E (demeclocycline, tolvaptan, conivaptan) are used for SIADH and would worsen hypernatremia by promoting free water loss. The stem provides sufficient detail to uniquely identify central DI and select desmopressin as the single best answer. Medical accuracy is excellent: the clinical presentation, diagnostic values, and treatment choice align with current endocrinology standards. No logical flaws or ambiguities exist. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes classic postoperative central diabetes insipidus (DI) after transsphenoidal pituitary surgery: polyuria (>300 mL/hr), hypernatremia (148 mEq/L), and dilute urine (specific gravity 1.002). Key discriminating findings are the surgical context (pituitary stalk injury), massive urine output, elevated serum sodium, and inappropriately dilute urine indicating ADH deficiency. The keyed answer (desmopressin) is the standard first-line treatment for central DI, directly replacing deficient ADH. Option B (hydrochlorothiazide) treats nephrogenic DI via paradoxical antidiuresis but is inappropriate for central DI. Options C, D, and E (demeclocycline, tolvaptan, conivaptan) are used for SIADH and would worsen hypernatremia by promoting free water loss. The stem provides sufficient detail to uniquely identify central DI and select desmopressin as the single best answer. Medical accuracy is excellent: the clinical presentation, diagnostic values, and treatment choice align with current endocrinology standards. No logical flaws or ambiguities exist. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-008", "question": "A 55-year-old man with idiopathic pulmonary fibrosis presents with acute worsening dyspnea. High-resolution CT shows new ground-glass opacities superimposed on fibrosis. Bronchoalveolar lavage reveals neutrophilia without infection. What is the most appropriate therapeutic approach?", "options": ["High-dose systemic corticosteroids", "Azathioprine addition to regimen", "Pirfenidone dose escalation", "Nintedanib initiation", "Lung transplantation evaluation"], "answer": "A", "answer_index": 0, "explanation": "High-dose systemic corticosteroids are the most appropriate for acute exacerbation of idiopathic pulmonary fibrosis, aiming to suppress inflammation despite limited evidence. Azathioprine is contraindicated due to increased mortality risk. Pirfenidone and nintedanib are antifibrotics for stable disease, not acute flares, and transplantation is for end-stage but not immediate management.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The vignette describes acute exacerbation of IPF (AE-IPF): acute worsening dyspnea, new ground-glass opacities on existing fibrosis, BAL neutrophilia without infection. Key discriminating findings are the acute presentation superimposed on chronic IPF and exclusion of infection. AE-IPF is a life-threatening complication requiring immediate intervention. Option A (high-dose corticosteroids) is the keyed answer and represents standard acute management despite limited evidence, as it targets the inflammatory component. Option B (azathioprine) is explicitly contraindicated per PANTHER-IPF trial showing increased mortality. Options C and D (pirfenidone/nintedanib) are chronic antifibrotics for stable disease, not acute exacerbations. Option E (transplant evaluation) is appropriate for end-stage disease but not immediate acute management. The stem provides sufficient detail to identify AE-IPF and discriminate acute from chronic management. Medical accuracy: The approach aligns with current practice where corticosteroids remain first-line for AE-IPF despite weak evidence, and azathioprine contraindication is well-established. No logical flaws or missing critical details. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes acute exacerbation of IPF (AE-IPF): acute worsening dyspnea, new ground-glass opacities on existing fibrosis, BAL neutrophilia without infection. Key discriminating findings are the acute presentation superimposed on chronic IPF and exclusion of infection. AE-IPF is a life-threatening complication requiring immediate intervention. Option A (high-dose corticosteroids) is the keyed answer and represents standard acute management despite limited evidence, as it targets the inflammatory component. Option B (azathioprine) is explicitly contraindicated per PANTHER-IPF trial showing increased mortality. Options C and D (pirfenidone/nintedanib) are chronic antifibrotics for stable disease, not acute exacerbations. Option E (transplant evaluation) is appropriate for end-stage disease but not immediate acute management. The stem provides sufficient detail to identify AE-IPF and discriminate acute from chronic management. Medical accuracy: The approach aligns with current practice where corticosteroids remain first-line for AE-IPF despite weak evidence, and azathioprine contraindication is well-established. No logical flaws or missing critical details. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-009", "question": "A 28-year-old man in the emergency department after a motor vehicle collision has hypotension, tachycardia, and abdominal distension. FAST exam shows free fluid in the abdomen. He is taken to the operating room for exploratory laparotomy, revealing a splenic laceration. What is the most appropriate intraoperative management for a hemodynamically unstable patient?", "options": ["Splenic artery embolization", "Partial splenectomy", "Splenorrhaphy with hemostatic agents", "Total splenectomy", "Non-operative management with observation"], "answer": "D", "answer_index": 3, "explanation": "Total splenectomy is the most appropriate for hemodynamically unstable patients with high-grade splenic injury to rapidly control bleeding and stabilize the patient. Embolization and non-operative management are for stable patients. Partial splenectomy or splenorrhaphy preserve splenic function but are time-consuming and risky in instability.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a hemodynamically unstable trauma patient (hypotension, tachycardia) with splenic laceration confirmed at laparotomy. Key discriminating findings: hemodynamic instability requiring emergent surgery. The question asks for most appropriate intraoperative management in this unstable patient. Option D (total splenectomy) is the established standard for hemodynamically unstable patients with splenic injury requiring laparotomy—it provides rapid, definitive hemorrhage control. Option A (embolization) requires interventional radiology and is reserved for stable patients; cannot be performed intraoperatively during laparotomy. Option E (non-operative management) contradicts the stem stating the patient is already in the OR undergoing laparotomy. Options B and C (splenic preservation techniques) are appropriate only for stable patients or lower-grade injuries; they are time-consuming and increase bleeding risk in unstable patients. The keyed answer aligns with ATLS principles and trauma surgery guidelines prioritizing damage control in unstable patients. No logical flaws or medical inaccuracies present. Minimal fix: None needed; item is valid as written.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a hemodynamically unstable trauma patient (hypotension, tachycardia) with splenic laceration confirmed at laparotomy. Key discriminating findings: hemodynamic instability requiring emergent surgery. The question asks for most appropriate intraoperative management in this unstable patient. Option D (total splenectomy) is the established standard for hemodynamically unstable patients with splenic injury requiring laparotomy—it provides rapid, definitive hemorrhage control. Option A (embolization) requires interventional radiology and is reserved for stable patients; cannot be performed intraoperatively during laparotomy. Option E (non-operative management) contradicts the stem stating the patient is already in the OR undergoing laparotomy. Options B and C (splenic preservation techniques) are appropriate only for stable patients or lower-grade injuries; they are time-consuming and increase bleeding risk in unstable patients. The keyed answer aligns with ATLS principles and trauma surgery guidelines prioritizing damage control in unstable patients. No logical flaws or medical inaccuracies present. Minimal fix: None needed; item is valid as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-010", "question": "A 65-year-old woman with rheumatoid arthritis develops shortness of breath. Echocardiography reveals severe mitral regurgitation with a flail leaflet. She has preserved left ventricular function but elevated pulmonary pressures. Coronary angiography is normal. What is the most appropriate intervention?", "options": ["Mitral valve repair", "Mitral valve replacement with bioprosthesis", "Transcatheter edge-to-edge repair", "Medical management with afterload reduction", "Cardiac resynchronization therapy"], "answer": "A", "answer_index": 0, "explanation": "Mitral valve repair is the most appropriate for severe primary mitral regurgitation due to flail leaflet in a surgical candidate, offering better durability and preservation of ventricular function compared to replacement. Transcatheter repair is for high-risk patients or functional regurgitation. Medical management and resynchronization do not address the structural defect.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem describes a 65-year-old woman with severe primary mitral regurgitation (MR) due to flail leaflet, preserved LV function, elevated pulmonary pressures, and normal coronaries—classic indications for surgical intervention. Key discriminating findings: (1) severe MR with flail leaflet (structural/degenerative pathology), (2) preserved LV function (good surgical candidate), (3) elevated pulmonary pressures (indication for intervention), (4) age 65 with RA (not explicitly high surgical risk). Mitral valve repair (A) is guideline-recommended first-line for degenerative MR with flail leaflet when feasible, offering superior outcomes versus replacement. Replacement (B) is reserved when repair is not feasible. Transcatheter edge-to-edge repair (C) is for prohibitive/high surgical risk or functional MR—nothing indicates she is high-risk. Medical management (D) does not address structural defect and is inappropriate for severe symptomatic primary MR. CRT (E) is irrelevant without dyssynchrony/heart failure indication. The item is logically valid with A as the unique best answer per current guidelines (ACC/AHA). Medical accuracy is high. Minimal fix: None needed; item is well-constructed and unambiguous.\", \"medical_accuracy_score\": \"5\", \"logical_validity\": true, \"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem describes a 65-year-old woman with severe primary mitral regurgitation (MR) due to flail leaflet, preserved LV function, elevated pulmonary pressures, and normal coronaries—classic indications for surgical intervention. Key discriminating findings: (1) severe MR with flail leaflet (structural/degenerative pathology), (2) preserved LV function (good surgical candidate), (3) elevated pulmonary pressures (indication for intervention), (4) age 65 with RA (not explicitly high surgical risk). Mitral valve repair (A) is guideline-recommended first-line for degenerative MR with flail leaflet when feasible, offering superior outcomes versus replacement. Replacement (B) is reserved when repair is not feasible. Transcatheter edge-to-edge repair (C) is for prohibitive/high surgical risk or functional MR—nothing indicates she is high-risk. Medical management (D) does not address structural defect and is inappropriate for severe symptomatic primary MR. CRT (E) is irrelevant without dyssynchrony/heart failure indication. The item is logically valid with A as the unique best answer per current guidelines (ACC/AHA). Medical accuracy is high. Minimal fix: None needed; item is well-constructed and unambiguous.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]